RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
1.040
-0.030 (-2.80%)
Nov 21, 2024, 11:03 AM EST - Market open
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $36.36 million as of November 21, 2024. Its market cap has decreased by -92.53% in one year.
Market Cap
36.36M
Enterprise Value
-55.38M
1-Year Change
-92.53%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has decreased from $276.64M to $36.36M, a decrease of -86.86%. That is a compound annual growth rate of -33.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 37.41M | -95.62% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | 484.97M | -19.54% |
| Dec 31, 2019 | 602.76M | 117.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rallybio | 39.84M |
| Adagio Medical Holdings | 39.68M |
| Anebulo Pharmaceuticals | 39.68M |
| BioLineRx | 39.47M |
| DIH Holding US | 38.52M |
| Lumos Pharma | 37.36M |
| Incannex Healthcare | 37.23M |
| Beyond Air | 36.73M |